CareLit Fachartikel

Glutarazidurie Typ 1: Behandelbare Störung des Lysinstoffwechsels

Teinert, J.; Boy, N. · MMW - Fortschritte der Medizin · 2025 · Heft 1 · S. 36 bis 37

Dokument
626010
CareLit-ID
Jahr
2025
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
MMW - Fortschritte der Medizin
Autor:innen
Teinert, J.; Boy, N.
Ausgabe
Heft 1 / 2025
Jahrgang 167
Seiten
36 bis 37
Erschienen: 2025-02-01 00:00:00
ISSN
1613-3560

Zusammenfassung

Glutaric aciduria type 1 (OMIM #231670) is a rare inherited neurometabolic disorder of lysine and tryptophan metabolism. The deficiency of mitochondrial glutaryl-CoA dehydrogenase activity leads to an accumulation of neurotoxic metabolites such as glutaric acid and 3-hydroxyglutaric acid in the body. Most untreated patients develop a dystonic movement disorder due to striatal injury during the first years of life associated with increased morbidity and mortality. However, early diagnosis and adherence to recommended metabolic treatment significantly improves neurological long-term outcome.

Schlagworte

Diagnosis Movement MMW - Fortschritte der Medizin